Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

0.710
-0.005-0.70%
Volume:34.81M
Turnover:24.91M
Market Cap:6.47B
PE:36.04
High:0.730
Open:0.720
Low:0.705
Close:0.715
52wk High:1.896
52wk Low:0.685
Shares:9.12B
HK Float Shares:9.12B
Volume Ratio:2.30
T/O Rate:0.38%
Dividend:0.01
Dividend Rate:1.58%
EPS(LYR):0.020
ROE:5.57%
ROA:2.80%
PB:0.90
PE(LYR):36.04
PS:2.10

Loading ...

Sihuan Pharma Appoints Song Xiaomi as CFO

Reuters
·
Aug 26

Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026

THOMSON REUTERS
·
Aug 26

Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026

THOMSON REUTERS
·
Aug 26

Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business

Stock News
·
Aug 20

Sihuan Pharmaceutical Sets 26 Aug 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend

Bulletin Express
·
Aug 14

Xuanzhu Biopharmaceutical Sets Board Meeting to Review Interim Results

Reuters
·
Aug 13

Sihuan Pharmaceutical Holdings Group (SEHK:460) Looks Pricey On 2026 Earnings Guidance

Simply Wall St.
·
Jul 28

Sihuan Pharmaceutical Hits Nearly 9-week High on Robust Earnings Estimates

Reuters
·
Jul 27

Hong Kong Stock Market Moves: SIHUAN PHARM Surges Over 4% as First-Half Net Profit Expected to Jump at Least 217.2% Year-on-Year, with Medical Aesthetics Business Maintaining Steady Growth

Stock News
·
Jul 27

Sihuan Pharmaceutical Expects H1 Profit to Soar At Least 217%

MT Newswires Live
·
Jul 27

Sihuan Pharmaceutical Shifts Bermuda Registered Office and Registrar to New Hamilton Address

Bulletin Express
·
Jul 27

SIHUAN PHARM Predicts First-Half Net Profit Surge of Over 217.2%

Stock News
·
Jul 27

Sihuan Pharma - Sees Hy Net Profit of not Less than Rmb210 Mln

THOMSON REUTERS
·
Jul 27

Sihuan Pharma - Expects H1 Revenue of at Least Rmb1,140 Mln and Net Profit of at Least Rmb210 Mln

THOMSON REUTERS
·
Jul 27

Xuanzhu Biopharma Ordered to Pay RMB 9.33 Million in Cietac Arbitration Award

Reuters
·
Jul 19

SIHUAN PHARM Shares Surge Over 12% in Early Trading Following Publication of Key Clinical Study

Stock News
·
Jul 14

Sihuan Pharma Says NMPA Accepts NDA for Anaprazole Sodium for Reflux Esophagitis

Reuters
·
Jul 06

Sihuan Pharmaceutical Holdings Group (SEHK:460) Following Phase III Trial Progress Is The Stock Too Pricey

Simply Wall St.
·
Jul 03

Sihuan Pharmaceutical Unit's Reflux Esophagitis Drug Application Accepted in China

MT Newswires Live
·
Jun 30

NMPA Accepts Sihuan Pharmaceutical Subsidiary Xuanzhu Biopharm’s NDA for Anaprazole Sodium in Reflux Esophagitis

Bulletin Express
·
Jun 30